390 related articles for article (PubMed ID: 37475842)
1. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas.
Souza-Tavares H; Miranda CS; Vasques-Monteiro IML; Sandoval C; Santana-Oliveira DA; Silva-Veiga FM; Fernandes-da-Silva A; Souza-Mello V
World J Gastroenterol; 2023 Jul; 29(26):4136-4155. PubMed ID: 37475842
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional fat cells, lipotoxicity and type 2 diabetes.
DeFronzo RA
Int J Clin Pract Suppl; 2004 Oct; (143):9-21. PubMed ID: 16035392
[TBL] [Abstract][Full Text] [Related]
3. Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor gamma (PPARgamma) and PPARgammacoactivator-1 (PGC1).
Medina-Gomez G; Gray S; Vidal-Puig A
Public Health Nutr; 2007 Oct; 10(10A):1132-7. PubMed ID: 17903321
[TBL] [Abstract][Full Text] [Related]
4. [The role of peroxisome proliferator-activated receptors γ (PPARγ) in obesity and insulin resistance].
Chmielewska-Kassassir M; Woźniak LA; Ogrodniczek P; Wójcik M
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1283-99. PubMed ID: 24379269
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease.
Souza-Mello V
World J Hepatol; 2015 May; 7(8):1012-9. PubMed ID: 26052390
[TBL] [Abstract][Full Text] [Related]
6. Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells.
Murakami T; Inagaki N; Kondoh H
Front Endocrinol (Lausanne); 2022; 13():869414. PubMed ID: 35432205
[TBL] [Abstract][Full Text] [Related]
7. PPARs and Metabolic Disorders Associated with Challenged Adipose Tissue Plasticity.
Corrales P; Vidal-Puig A; Medina-Gómez G
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037087
[TBL] [Abstract][Full Text] [Related]
8. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
[TBL] [Abstract][Full Text] [Related]
9. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.
Fuentes L; Roszer T; Ricote M
Mediators Inflamm; 2010; 2010():219583. PubMed ID: 20508742
[TBL] [Abstract][Full Text] [Related]
11. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
[TBL] [Abstract][Full Text] [Related]
12. Blueberry intake alters skeletal muscle and adipose tissue peroxisome proliferator-activated receptor activity and reduces insulin resistance in obese rats.
Seymour EM; Tanone II; Urcuyo-Llanes DE; Lewis SK; Kirakosyan A; Kondoleon MG; Kaufman PB; Bolling SF
J Med Food; 2011 Dec; 14(12):1511-8. PubMed ID: 21861718
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
[TBL] [Abstract][Full Text] [Related]
14. Enhanced pan-peroxisome proliferator-activated receptor gene and protein expression in adipose tissue of diet-induced obese mice treated with telmisartan.
Penna-de-Carvalho A; Graus-Nunes F; Rabelo-Andrade J; Mandarim-de-Lacerda CA; Souza-Mello V
Exp Physiol; 2014 Dec; 99(12):1663-78. PubMed ID: 25326526
[TBL] [Abstract][Full Text] [Related]
15. Monosodium glutamate neonatal intoxication associated with obesity in adult stage is characterized by chronic inflammation and increased mRNA expression of peroxisome proliferator-activated receptors in mice.
Roman-Ramos R; Almanza-Perez JC; Garcia-Macedo R; Blancas-Flores G; Fortis-Barrera A; Jasso EI; Garcia-Lorenzana M; Campos-Sepulveda AE; Cruz M; Alarcon-Aguilar FJ
Basic Clin Pharmacol Toxicol; 2011 Jun; 108(6):406-13. PubMed ID: 21205225
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.
Francque S; Szabo G; Abdelmalek MF; Byrne CD; Cusi K; Dufour JF; Roden M; Sacks F; Tacke F
Nat Rev Gastroenterol Hepatol; 2021 Jan; 18(1):24-39. PubMed ID: 33093663
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activation of peroxisome proliferator-activated receptor δ improves insulin resistance and hepatic steatosis in high fat diet-induced diabetic mice.
Wu HT; Chen CT; Cheng KC; Li YX; Yeh CH; Cheng JT
Horm Metab Res; 2011 Aug; 43(9):631-5. PubMed ID: 21725906
[TBL] [Abstract][Full Text] [Related]
18. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
19. PPARs-Orchestrated Metabolic Homeostasis in the Adipose Tissue.
Sun C; Mao S; Chen S; Zhang W; Liu C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445679
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
